Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01947036 · ClinicalTrials.gov registry record
T and B Cell Responses in Autoimmune Diseases
A clinical trial, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- Terminated
- Registry status
- 68
- Enrollment target
NCT01947036 is a clinical trial that was terminated before completion, run by National Institute of Allergy and Infectious Diseases (NIAID). The registered enrollment target is 68 participants.
The verdict
NCT01947036 was terminated before completion, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- TERMINATED
- Registry status
- 68 participants
- Enrollment target
Study Summary
The study aims to establish whether defects in immune cell function are shared across multiple autoimmune diseases and whether those problems match to similar genes in the cells.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 68 participants |
| Start Date | 2014-01 |
| Est. Completion | 2015-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01947036
The ClinicalTrials.gov registry entry for NCT01947036 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 68 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01947036 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01947036 about?
NCT01947036 is a clinical study titled "T and B Cell Responses in Autoimmune Diseases". The study aims to establish whether defects in immune cell function are shared across multiple autoimmune diseases and whether those problems match to similar genes in the cells.
What is the current status of trial NCT01947036?
This trial is currently terminated. The enrollment target is 68 participants. The study started on 2014-01. Estimated completion is 2015-10.
Who is sponsoring clinical trial NCT01947036?
This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.